Centrifuge has integrated Symbiotic's Liquid Lane across three tokenized funds with approximately $1.6 billion in assets under management, enabling eligible holders to exchange their positions for USDC immediately. The integration covers Janus Henderson's JAAA, an AAA-rated collateralized loan obligation strategy, its JTRSY, a short-duration U.S. Treasury strategy, and New York Life Investment Management's HYB, a U.S. high-yield corporate bond strategy.

Janus Henderson, overseeing about $500 billion in assets, has been a primary driver of Centrifuge's expansion through its JAAA and JTRSY offerings. By December 2025, Centrifuge had attracted approximately $1.3 billion in new capital inflows, predominantly from the two Janus Henderson funds. The JAAA fund alone accounted for about $1 billion in total value locked.

Symbiotic's Liquid Lane operates as an on-chain request-for-quote marketplace where market makers access liquidity from vaults to fulfill redemption requests, providing investors immediate USDC while standard redemption processes occur separately. After acquiring fund tokens through the RFQ marketplace, market makers can redeem them directly from the issuer or resell them via another RFQ transaction.

Centrifuge previously partnered with Wintermute in February 2025 to facilitate 24/7 instant redemptions for JTRSY. The HYB fund launched in June with its own separate redemption arrangement.

Liquid Lane's primary distinction lies in its capital structure, said Felix Lutsch, Symbiotic's head of ecosystem. The marketplace enables multiple market makers and curators to participate without requiring them to pre-fund and carry inventory for each individual asset.

Historically, low trading volumes in tokenized assets have offered minimal incentive for market makers to commit capital, Lutsch said. This constraint has limited liquidity depth in the sector. Aggregating redemption demand across different issuers and asset classes could improve the economics for market makers, particularly as tokenized funds see increased use as collateral and financing assets within on-chain markets, Lutsch said.

Symbiotic is backed by Paradigm, Pantera Capital, cyber•Fund and Coinbase Ventures.